ISIS 2503

ISIS-2503 · Ionis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ISIS 2503, covering 2011-01-04 to 2016-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas [Phase 2]